SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-24-033430
Filing Date
2024-04-16
Accepted
2024-04-16 16:06:24
Documents
1
Period of Report
2024-04-16

Document Format Files

Seq Description Document Type Size
1 PRELIMINARY PROXY STATEMENT ea0203874-pre14a_unicycive.htm PRE 14A 723309
  Complete submission text file 0001213900-24-033430.txt   724365
Mailing Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022
Business Address 4300 EL CAMINO REAL, SUITE 210 LOS ALTOS CA 94022 650-384-0642
Unicycive Therapeutics, Inc. (Filer) CIK: 0001766140 (see all company filings)

IRS No.: 813638692 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40582 | Film No.: 24847850
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)